Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-23 Purchase |
2024-12-26 4:01 pm |
Marker Therapeutics Inc. | MRKR | ELMS STEVE Director |
11,085 | $3.2 | $35,472 | 328,338 (Indirect Direct) |
View |
| 2024-12-23 Purchase |
2024-12-23 4:40 pm |
Marker Therapeutics Inc. | MRKR | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC BASKETT FOREST Chang Carmen Behbahani Ali Florence Anthony A. Jr. Makhzoumi Mohamad SANDELL SCOTT D Walker Paul Edward 10% Owner |
554,250 | $3.2 | $1,773,600 | 1,625,678 (Direct) |
View |
| 2021-03-16 Purchase |
2023-06-08 9:35 pm |
Marker Therapeutics Inc. | MRKR | Eansor Norman David Director |
14,285 | $17.5 | $249,988 | 17,570 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-12 Option Award |
2025-02-14 5:20 pm |
N/A 2035-02-12 |
Marker Therapeutics Inc. | MRKR | ELMS STEVE Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 5:19 pm |
N/A 2035-02-12 |
Marker Therapeutics Inc. | MRKR | Knobil Katharine Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 5:18 pm |
N/A 2035-02-12 |
Marker Therapeutics Inc. | MRKR | Eansor Norman David Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 5:17 pm |
N/A 2035-02-12 |
Marker Therapeutics Inc. | MRKR | Vera Juan President and CEO |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 9:35 pm |
N/A 2033-06-05 |
Marker Therapeutics Inc. | MRKR | Eansor Norman David Director |
8,000 | $0 | 17,570 (Direct) |
View |
| 2021-03-25 Gift |
2023-06-08 9:35 pm |
N/A N/A |
Marker Therapeutics Inc. | MRKR | Eansor Norman David Director |
21,427 | $0 | 17,570 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 9:34 pm |
N/A 2033-06-05 |
Marker Therapeutics Inc. | MRKR | Knobil Katharine Director |
8,000 | $0 | 8,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 9:33 pm |
N/A 2033-06-05 |
Marker Therapeutics Inc. | MRKR | Wilson John Robert Director |
8,000 | $0 | 8,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 9:32 pm |
N/A 2033-06-05 |
Marker Therapeutics Inc. | MRKR | ELMS STEVE Director |
8,000 | $0 | 8,000 (Direct) |
View |
| 2023-05-10 Option Award |
2023-05-11 6:10 pm |
N/A 2033-05-10 |
Marker Therapeutics Inc. | MRKR | Vera Juan President and CEO |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-02-27 Option Award |
2023-03-01 4:52 pm |
N/A 2033-02-27 |
Marker Therapeutics Inc. | MRKR | Hoang Tsvetelina P VP, Research and Development |
33,159 | $0 | 33,159 (Direct) |
View |
| 2023-02-27 Option Award |
2023-03-01 4:51 pm |
N/A 2033-02-27 |
Marker Therapeutics Inc. | MRKR | Koneru Mythili Chief Medical Officer |
51,918 | $0 | 51,918 (Direct) |
View |
| 2023-02-27 Option Award |
2023-03-01 4:50 pm |
N/A 2033-02-27 |
Marker Therapeutics Inc. | MRKR | Loiacono Michael Chief Accounting Officer |
38,480 | $0 | 38,480 (Direct) |
View |
| 2023-02-27 Option Award |
2023-03-01 4:49 pm |
N/A 2033-02-27 |
Marker Therapeutics Inc. | MRKR | Vera Juan Chief Scientific Officer & COO |
46,487 | $0 | 46,487 (Direct) |
View |
| 2023-02-27 Option Award |
2023-03-01 4:48 pm |
N/A 2033-02-27 |
Marker Therapeutics Inc. | MRKR | Szymanska Anna Vice President, Quality |
29,947 | $0 | 29,947 (Direct) |
View |
| 2023-02-27 Option Award |
2023-03-01 4:47 pm |
N/A 2033-02-27 |
Marker Therapeutics Inc. | MRKR | Agopyan Nadia SVP, Regulatory Affairs |
34,154 | $0 | 34,154 (Direct) |
View |
| 2022-05-24 Option Award |
2022-05-26 4:12 pm |
N/A 2032-05-23 |
Marker Therapeutics Inc. | MRKR | Wilson John Robert Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2022-05-24 Option Award |
2022-05-26 4:10 pm |
N/A 2032-05-23 |
Marker Therapeutics Inc. | MRKR | Laskow-Pooley David Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2022-05-24 Option Award |
2022-05-26 4:10 pm |
N/A 2032-05-23 |
Marker Therapeutics Inc. | MRKR | Knobil Katharine Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2022-05-24 Option Award |
2022-05-26 4:09 pm |
N/A 2032-05-23 |
Marker Therapeutics Inc. | MRKR | ELMS STEVE Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2022-05-24 Option Award |
2022-05-26 4:08 pm |
N/A 2032-05-23 |
Marker Therapeutics Inc. | MRKR | Eansor Norman David Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2022-03-24 Tax Withholding |
2022-03-28 9:06 pm |
N/A N/A |
Marker Therapeutics Inc. | MRKR | Hoang Peter L. President and CEO |
48,376 | $0.4848 | 483,286 (Direct) |
View |
| 2022-03-24 Option Award |
2022-03-28 9:06 pm |
N/A N/A |
Marker Therapeutics Inc. | MRKR | Hoang Peter L. President and CEO |
199,094 | $0 | 483,286 (Direct) |
View |
| 2022-03-24 Tax Withholding |
2022-03-28 9:04 pm |
N/A N/A |
Marker Therapeutics Inc. | MRKR | Vera Juan Chief Scientific Officer & COO |
33,465 | $0.4848 | 2,671,845 (Direct) |
View |
| 2022-03-24 Option Award |
2022-03-28 9:04 pm |
N/A N/A |
Marker Therapeutics Inc. | MRKR | Vera Juan Chief Scientific Officer & COO |
140,823 | $0 | 2,671,845 (Direct) |
View |
| 2022-03-24 Tax Withholding |
2022-03-28 9:03 pm |
N/A N/A |
Marker Therapeutics Inc. | MRKR | Kim Anthony H. Chief Financial Officer |
36,076 | $0.4848 | 114,436 (Direct) |
View |
| 2022-03-24 Option Award |
2022-03-28 9:03 pm |
N/A N/A |
Marker Therapeutics Inc. | MRKR | Kim Anthony H. Chief Financial Officer |
150,512 | $0 | 114,436 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 5:14 pm |
N/A 2032-02-17 |
Marker Therapeutics Inc. | MRKR | Hoang Peter L. President and CEO |
430,000 | $0 | 430,000 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 5:12 pm |
N/A 2032-02-17 |
Marker Therapeutics Inc. | MRKR | Vera Juan Chief Scientific Officer & COO |
160,000 | $0 | 160,000 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 5:10 pm |
N/A 2032-02-17 |
Marker Therapeutics Inc. | MRKR | Szymanska Anna Vice President, Quality |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 5:09 pm |
N/A 2032-02-17 |
Marker Therapeutics Inc. | MRKR | Loiacono Michael Chief Accounting Officer |
140,000 | $0 | 140,000 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 5:07 pm |
N/A 2032-02-17 |
Marker Therapeutics Inc. | MRKR | Koneru Mythili Chief Medical Officer |
160,000 | $0 | 160,000 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 5:06 pm |
N/A 2032-02-17 |
Marker Therapeutics Inc. | MRKR | Kim Anthony H. Chief Financial Officer |
160,000 | $0 | 160,000 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 5:04 pm |
N/A 2032-02-17 |
Marker Therapeutics Inc. | MRKR | Hoang Tsvetelina P VP, Research and Development |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 5:02 pm |
N/A 2032-02-17 |
Marker Therapeutics Inc. | MRKR | Garrett Gerald Vice President, Clinical Ops. |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 5:01 pm |
N/A 2032-02-17 |
Marker Therapeutics Inc. | MRKR | Agopyan Nadia VP, Regulatory Affairs |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-09 5:20 pm |
N/A 2031-12-07 |
Marker Therapeutics Inc. | MRKR | Knobil Katharine Director |
125,000 | $0 | 125,000 (Direct) |
View |
Ownership |
2021-12-09 5:18 pm |
N/A N/A |
Marker Therapeutics Inc. | MRKR | Knobil Katharine Director |
0 | $0 | 1,500 (Indirect) |
View |
| 2021-06-08 Option Award |
2021-06-10 6:57 pm |
N/A N/A |
Marker Therapeutics Inc. | MRKR | Wasserman Frederick Gerald Director |
12,658 | $0 | 65,223 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 6:56 pm |
N/A N/A |
Marker Therapeutics Inc. | MRKR | Laskow-Pooley David Director |
12,658 | $0 | 55,223 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 6:55 pm |
N/A N/A |
Marker Therapeutics Inc. | MRKR | ELMS STEVE Director |
12,658 | $0 | 3,172,537 (Direct) |
View |